Xvivo Perfusion AB (XVIVO) — Capital Reinvestment Ratio
Latest as of December 2025:
1.00x
Xvivo Perfusion AB (XVIVO) has a Capital Reinvestment Ratio of 1.00x as of December 2025, meaning it reinvests 1% of its operating cash flow (Skr86.93 Million) in capital expenditures (Skr86.93 Million). See XVIVO FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
1.00x
Capex / Operating Cash Flow
Operating Cash Flow
Skr86.93 Million
SEK
Capital Expenditures
Skr86.93 Million
SEK
Data as of
Dec 2025
Most recent filing
Xvivo Perfusion AB Capital Reinvestment Ratio (2011–2025)
This chart tracks Xvivo Perfusion AB's Capital Reinvestment Ratio across 12 annual periods.
Annual Capital Reinvestment Ratio for Xvivo Perfusion AB (2011–2025)
Year-by-year Capital Reinvestment Ratio for Xvivo Perfusion AB from 2011 to 2025. For live market cap and broader valuation context, see Xvivo Perfusion AB (XVIVO) total market value.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.00x | Skr101.07 Million | Skr101.07 Million | ▼ -42.4% |
| 2024 | 1.74x | Skr111.29 Million | Skr193.15 Million | ▲ +86.8% |
| 2023 | 0.93x | Skr46.29 Million | Skr43.02 Million | ▼ -80.2% |
| 2022 | 4.70x | Skr27.86 Million | Skr130.95 Million | ▲ +65.7% |
| 2019 | 2.84x | Skr29.50 Million | Skr83.69 Million | ▲ +22.5% |
| 2018 | 2.32x | Skr23.63 Million | Skr54.71 Million | ▲ +47.1% |
| 2017 | 1.57x | Skr22.19 Million | Skr34.93 Million | ▼ -3.7% |
| 2016 | 1.63x | Skr12.55 Million | Skr20.51 Million | ▲ +6.1% |
| 2015 | 1.54x | Skr8.58 Million | Skr13.21 Million | ▲ +64.7% |
| 2013 | 0.94x | Skr13.46 Million | Skr12.59 Million | ▼ -47.3% |
| 2012 | 1.77x | Skr1.67 Million | Skr2.96 Million | ▲ +96549.9% |
| 2011 | 0.00x | Skr14.17 Million | Skr26.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow